La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 25 000 €. L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies
April 30, 2024 10:30 ET
|
Biocodex Canada
MONTRÉAL, 30 avr. 2024 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le...
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases
April 30, 2024 10:30 ET
|
Biocodex Canada
Bourse de recherche de 25 000$ de la Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens.
L’Alliance Promotion Microbiote accueille Ferring Pharmaceuticals, Pelican Health et Polepharma en tant que nouveaux membres
November 09, 2023 10:00 ET
|
ALLIANCE PROMOTION MICROBIOTE
Lyon- France – 9 novembre 2023 – L’Alliance Promotion Microbiote (APM), acteur majeur dédié au développement, à la production et à la commercialisation d’innovations thérapeutiques basées sur le...
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
November 09, 2023 10:00 ET
|
ALLIANCE PROMOTION MICROBIOTE
Lyon – France, November 9th, 2023 – Alliance Promotion Microbiote (APM), a leading player dedicated to the development, the production, and the commercialization of therapeutic innovations based on...
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
July 31, 2023 16:20 ET
|
Biocodex Canada
The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome MONTREAL, July 31,...
EnteroBiotix appoints Elmar Schnee as Executive Chairman
July 17, 2023 03:00 ET
|
EnteroBiotix
GLASGOW, Scotland, July 17, 2023 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage company with the premier platform for full-spectrum microbiome therapeutics, today announced the...
Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022 08:30 ET
|
Summit Therapeutics Inc.
Menlo Park, California, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
October 20, 2022 17:15 ET
|
Summit Therapeutics Inc.
Ridinilazole resulted in a 53% relative risk reduction in recurrence of C. difficile infection compared to treatment with vancomycin Ridinilazole preserved the gut microbiome compared to...
Summit Therapeutics to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
October 13, 2022 08:00 ET
|
Summit Therapeutics Inc.
Menlo Park, California, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) and its product candidate, ridinilazole, will have an oral podium...
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
August 04, 2022 10:26 ET
|
Biocodex Canada
The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome MONTREAL, Aug. 04,...